{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T01:56:44Z","timestamp":1773194204499,"version":"3.50.1"},"reference-count":38,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The combined use of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is employed for the treatment of peritoneal carcinomatosis (PC). To achieve optimal cytoreduction, there may be a need for extensive resection and subsequent reconstruction of urologic structures. This study was designed to evaluate the outcomes of urinary tract resection or repair performed in CRS\/HIPEC in terms of operative and oncological outcomes. Materials and Methods: After institutional review board approval, data from 550 consecutive patients who underwent the CRS\/HIPEC procedure from January 2007 to July 2018 at six university hospitals was retrieved from prospectively maintained databases. Data from patients who had a concomitant curative resection and reconstruction of the bladder, ureter, or kidney during the CRS\/HIPEC procedure were analyzed retrospectively. Results: A total of 50 out of 550 patients had undergone resection with a repair of the urinary tract due to tumor invasion or iatrogenic injury. Postoperative (within 30 days) urologic complications were observed in 9 of the 50 patients. It was found that having a peritoneal cancer index (PCI) equal to or greater than 20 (p &lt; 0.009) was the sole significant risk factor associated with the occurrence of early urinary complications. Survival time post CRS\/HIPEC treatment did not significantly differ between patients with and without urologic complications (median overall survival: 23 vs. 27 months, p = 0.683). Conclusions: Despite urinary tract issues during CRS\/HIPEC for PC, including a PCI over 20 and potential complications from resection or repair, the procedure still offers significant survival benefits.<\/jats:p>","DOI":"10.3390\/medicina61081331","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T14:22:44Z","timestamp":1753280564000},"page":"1331","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management and Outcomes of Urinary Tract Involvement in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS\/HIPEC): A Retrospective Cohort Study"],"prefix":"10.3390","volume":"61","author":[{"given":"Feza","family":"Karakayali","sequence":"first","affiliation":[{"name":"Department of Surgery, Baskent University Istanbul Hospital, Istanbul 34662, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-543X","authenticated-orcid":false,"given":"Melik Kagan","family":"Aktas","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erman","family":"Aytac","sequence":"additional","affiliation":[{"name":"Gastrointestinal Oncology Unit, Acibadem University Atakent Hospital, Istanbul 34303, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur","family":"Sungurtekin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Pamukkale University, Denizli 20160, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sezai","family":"Demirbas","sequence":"additional","affiliation":[{"name":"Department of Surgery, TOBB University, Ankara 06510, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Oncel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medipol University, Istanbul 34214, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-5101","authenticated-orcid":false,"given":"Ersin","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Surgery, Bursa Medicana Hospital, Bursa 16110, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahsin","family":"Colak","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mersin University, Mersin 33110, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Ince","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yuzuncu Yil Hospital, Ankara 06530, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Haksal","sequence":"additional","affiliation":[{"name":"Department of Surgery, Medipol University, Istanbul 34214, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8443-1497","authenticated-orcid":false,"given":"Safak","family":"Coskun","sequence":"additional","affiliation":[{"name":"Department of Surgery, Baskent University Istanbul Hospital, Istanbul 34662, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8235-7246","authenticated-orcid":false,"given":"Selman","family":"Sokmen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dokuz Eylul University, Izmir 35330, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","article-title":"Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann. Surg."},{"key":"ref_2","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt","year":"1980","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/BF02048443","article-title":"Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis","volume":"37","author":"Sugarbaker","year":"1994","journal-title":"Dis. Colon Rectum"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13193-018-0856-1","article-title":"Prevention and treatment of peritoneal metastases: A comprehensive review","volume":"10","author":"Sugarbaker","year":"2019","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jso.20427","article-title":"Pseudomyxoma peritonei and the urinary tract: Involvement and treatment related complications","volume":"93","author":"Smeenk","year":"2006","journal-title":"J. Surg. Oncol."},{"key":"ref_6","first-page":"295","article-title":"Urological procedures in patients with peritoneal carcinomatosis of colorectal cancer treated with HIPEC: Morbidity and survival analysis","volume":"35","author":"Braam","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","article-title":"Management of peritoneal-surface malignancy: The surgeon\u2019s role","volume":"384","author":"Sugarbaker","year":"1999","journal-title":"Langenbeck\u2019s Arch. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/DCR.0000000000002315","article-title":"Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review","volume":"65","author":"Parikh","year":"2022","journal-title":"Dis. Colon Rectum"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yurttas, C., Hoffmann, G., Tolios, A., Haen, S.P., Schwab, M., Koenigsrainer, I., Koenigsrainer, A., Beckert, S., and Loeffler, M.W. (2018). Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer. J. Clin. Med., 7.","DOI":"10.3390\/jcm7120567"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1002\/cncr.25116","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis","volume":"116","author":"Franko","year":"2010","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/PPO.0b013e3181a58d7c","article-title":"Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy","volume":"15","author":"Verwaal","year":"2009","journal-title":"Cancer J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1245\/s10434-009-0487-4","article-title":"A systematic review and metaanalysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin","volume":"16","author":"Cao","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","article-title":"Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: A two-center study of 101 patients","volume":"57","author":"Baratti","year":"2014","journal-title":"Dis. Colon Rectum"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejso.2010.10.014","article-title":"Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O","volume":"37","author":"Cavaliere","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","article-title":"Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis","volume":"254","author":"Quenet","year":"2011","journal-title":"Ann. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1245\/s10434-018-6539-x","article-title":"Metachronous peritoneal metastases after adjuvant chemotherapy are associated with poor outcome after cytoreduction and HIPEC","volume":"25","author":"Sluiter","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SLA.0b013e318255486a","article-title":"Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis","volume":"256","author":"Passot","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: Retrospective analysis of 523 patients from a multicentric french study","volume":"28","author":"Elias","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1245\/s10434-011-1820-2","article-title":"HIPEC for peritoneal carcinomatosis: Does an associated urologic procedure increase morbidity?","volume":"19","author":"Souadka","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1245\/s10434-013-3354-2","article-title":"Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"21","author":"Votanopoulos","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1097\/01.AOG.0000220500.83528.6e","article-title":"Rates of urinary tract injury from gynecologic surgery and the role of intraoperative cystoscopy","volume":"107","author":"Gilmour","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00192-008-0788-3","article-title":"Prophylactic ureteral catheterization in gynecologic surgery: A 12-year randomized trial in a community hospital","volume":"20","author":"Chou","year":"2009","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000339920","article-title":"Ureteral stenting in cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy as a routine procedure: Evidence and necessity","volume":"89","author":"Coccolini","year":"2012","journal-title":"Urol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer. Treat. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9","article-title":"Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy","volume":"92","author":"Elias","year":"2001","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: Five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4613-1245-1_13","article-title":"Peritoneal carcinomatosis: Natural history and rational therapeutic interventions using intraperitoneal chemotherapy","volume":"81","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jso.24153","article-title":"Cytoreductive surgery and hyperthermic intraper-itoneal chemotherapy in patients with liver involvement","volume":"113","author":"Berger","year":"2016","journal-title":"J. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jso.24115","article-title":"Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"113","author":"Lyon","year":"2016","journal-title":"J. Surg. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1245\/s10434-013-3393-8","article-title":"Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: A case-matched study","volume":"21","author":"Leapman","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jviscsurg.2017.01.002","article-title":"Reconstruction after ureteral resection during HIPEC surgery: Re-implantation with uretero-neocystostomy seems safer than end-to-end anastomosis","volume":"154","author":"Pinar","year":"2017","journal-title":"J. Visc. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): A multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Elias","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pereira, F., Serrano, A., Manzanedo, I., P\u00e9rez-Viejo, E., Gonz\u00e1lez-Moreno, S., Gonz\u00e1lez-Bay\u00f3n, L., Arjona-S\u00e1nchez, A., Torres, J., Ramos, I., and Barrios, M.E. (2022). GECOP-MMC: Phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09572-7"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23722","article-title":"The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"110","author":"Esquivel","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_37","first-page":"45","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus R0 resection for resectable colorectal cancer with peritoneal metastases and low peritoneal cancer index scores: A collaborative observational study from Korea and Japan","volume":"110","author":"Kitaguchi","year":"2023","journal-title":"Int. J. Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12957-024-03457-8","article-title":"Intraoperative urinary tract resection and construction in CRS + HIPEC procedures: A single center retrospective analysis","volume":"22","author":"Ji","year":"2024","journal-title":"World J. Surg. Oncol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1331\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:48Z","timestamp":1760033688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081331"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081331","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}